Renalytix - Return on Investment 2020-2024 | RNLXY
Renalytix - ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2024-09-30 | $-0.02B | $-0.01B | 480.00% |
2024-06-30 | $-0.03B | $0.00B | 1288.89% |
2024-03-31 | $-0.03B | $-0.01B | -1466.67% |
2023-12-31 | $-0.04B | $0.00B | -380.00% |
2023-09-30 | $-0.04B | $0.00B | -271.19% |
2023-06-30 | $-0.04B | $0.01B | -215.00% |
2023-03-31 | $-0.05B | $0.03B | -176.92% |
2022-12-31 | $-0.05B | $0.02B | -253.16% |
2022-09-30 | $-0.05B | $0.03B | -342.86% |
2022-06-30 | $-0.05B | $0.04B | -568.42% |
2022-03-31 | $-0.05B | 0.00% | |
2021-12-31 | $-0.04B | -220.00% | |
2021-09-30 | $-0.04B | -93.41% | |
2021-06-30 | $-0.03B | -50.39% | |
2021-03-31 | $-0.03B | $0.08B | -37.04% |
2020-12-31 | $-0.02B | $0.09B | -42.11% |
2020-09-30 | $-0.01B | $0.09B | -54.37% |
2020-06-30 | $-0.01B | $0.02B | -275.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.029B | $0.002B |
Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.738B | 59.46 |
Hims & Hers Health (HIMS) | United States | $12.987B | 134.93 |
Doximity (DOCS) | United States | $11.457B | 53.04 |
Tempus AI (TEM) | United States | $11.228B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.880B | 60.62 |
Hinge Health (HNGE) | United States | $3.671B | 0.00 |
Privia Health (PRVA) | United States | $2.475B | 169.17 |
Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
Schrodinger (SDGR) | United States | $1.690B | 0.00 |
10x Genomics (TXG) | United States | $1.677B | 0.00 |
Phreesia (PHR) | United States | $1.648B | 0.00 |
Enovis (ENOV) | United States | $1.582B | 8.82 |
Azenta (AZTA) | United States | $1.578B | 73.36 |
Omnicell (OMCL) | United States | $1.321B | 23.31 |
Evolent Health (EVH) | United States | $1.199B | 102.10 |
Claritev (CTEV) | United States | $0.719B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.575B | 0.00 |
Standard BioTools (LAB) | United States | $0.551B | 0.00 |
Butterfly Network (BFLY) | United States | $0.532B | 0.00 |
Veradigm (MDRX) | United States | $0.503B | 0.00 |
Talkspace (TALK) | United States | $0.438B | 131.00 |
TruBridge (TBRG) | United States | $0.347B | 770.33 |
Outset Medical (OM) | United States | $0.345B | 0.00 |
Health Catalyst (HCAT) | United States | $0.282B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
CapsoVision (CV) | United States | $0.197B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.176B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
Pulmonx (LUNG) | United States | $0.152B | 0.00 |
American Well (AMWL) | United States | $0.134B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.122B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
CareCloud (CCLD) | United States | $0.105B | 3.98 |
Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
111 (YI) | China | $0.064B | 0.00 |
P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
HeartBeam (BEAT) | United States | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.026B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |